147 results
Page 4 of 8
424B5
mf8xpbr1flcqd17n
26 Mar 20
Prospectus supplement for primary offering
9:33pm
8-K
EX-1.1
q9ufdi
12 Feb 20
Entry into a Material Definitive Agreement
4:55pm
424B5
4avx4bzq
12 Feb 20
Prospectus supplement for primary offering
9:05am
8-K
EX-3.1
ady1jy3 jrq1ieq
20 Jun 19
ContraVir Pharmaceuticals, Inc. Announces Pricing of $15.6 Million Public Offering
4:30pm
424B4
emmv9n eszhsyvcv9
19 Jun 19
Prospectus supplement with pricing info
5:25pm
8-K
EX-3.1
fwsutc4hgbez346ord8j
8 May 19
Amendments to Articles of Incorporation or Bylaws
4:34pm
424B4
hw2glh287g0jr rk
26 Apr 19
Prospectus supplement with pricing info
3:56pm